Metabolic stabilization of the chemical lead 1, which is a structurally novel inhibitor of TNF-alpha production, was accomplished by introducing a (1S)-methyl group into the optically active backbone. As a result, 2, 3 and 4 were identified as drug candidates and evaluated pharmacologically. The analysis of an active conformer was also carried out.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0960-894x(02)00037-9 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!